Compile Data Set for Download or QSAR
Report error Found 25 Enz. Inhib. hit(s) with all data for entry = 9324
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458361BDBM458361(US10752626, Compound 17)
Affinity DataIC50: 1.50E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458362BDBM458362(US10752626, Compound 18)
Affinity DataIC50: 1.50E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458359BDBM458359(US10752626, Compound 15)
Affinity DataIC50: 1.50E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458360BDBM458360(US10752626, Compound 16)
Affinity DataIC50: 1.50E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458369BDBM458369(US10752626, Compound 31)
Affinity DataIC50: 1.50E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458367BDBM458367(US10752626, Compound 23)
Affinity DataIC50: 1.50E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458368BDBM458368(US10752626, Compound 24)
Affinity DataIC50: 1.50E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458365BDBM458365(US10752626, Compound 21)
Affinity DataIC50: 1.50E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458366BDBM458366(US10752626, Compound 22)
Affinity DataIC50: 1.50E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458363BDBM458363(US10752626, Compound 19)
Affinity DataIC50: 1.50E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458364BDBM458364(US10752626, Compound 20)
Affinity DataIC50: 5.75E+3nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458357BDBM458357(US10752626, Compound 13)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458358BDBM458358(US10752626, Compound 14)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458355BDBM458355(US10752626, Compound 11)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458356BDBM458356(US10752626, Compound 12)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458353BDBM458353(US10752626, Compound 9)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458354BDBM458354(US10752626, Compound 10)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458351BDBM458351(US10752626, Compound 7)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458352BDBM458352(US10752626, Compound 8)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458349BDBM458349(US10752626, Compound 5)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458350BDBM458350(US10752626, Compound 6)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458347BDBM458347(US10752626, Compound 3)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458348BDBM458348(US10752626, Compound 4)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458345BDBM458345(US10752626, Compound 1)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132C](Human)
Shanghai Meton Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 458346BDBM458346(US10752626, Compound 2)
Affinity DataIC50: 1.25E+4nMAssay Description:Solution A was prepared by combining 1 M Tris-HCl pH7.5 (300 μL), 5 M NaCl (450 μL), 1 M MgCl2 (150 μL), 1 M DTT (15 μL), 20 mg/m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent